Quantification of epidermal growth factor receptor (EGFR) mutation may be a predictor of EGFR‐tyrosine kinase inhibitor treatment response

BACKGROUND: Epidermal growth factor receptor (EGFR) gene mutation is a reliable predictive factor for response to EGFR‐tyrosine kinase inhibitors (TKIs). The quantified EGFR value may also predict response and survival within an EGFR mutated group. METHODS: We conducted a retrospective study of 836...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Thorac Cancer
Autors principals: Park, Ha Young, Oh, Hyung Joo, Kim, Ki‐Hyun, Kim, Tae‐Ok, Park, Cheol‐Kyu, Shin, Hong‐Jun, Lim, Jung‐Hwan, Kwon, Yong‐Soo, Oh, In‐Jae, Kim, Yu‐Il, Lim, Sung‐Chul, Kim, Young‐Chul, Choi, Yoo‐Duk
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons Australia, Ltd 2016
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5093171/
https://ncbi.nlm.nih.gov/pubmed/27755804
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12378
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars